Asia Pacific Nuclear Imaging Industry by Diagnostic Technologies (PET Radioisotopes-(Rubidium-82, Fluorine-18, and Others), SPECT Radioisotopes-(Thallium-201, Technetium-99m, Xenon-133, Iodine-123, and Others)), by Application (PET-(Cardiology, Oncology, Neurology, and Others), SPECT-(Lymphoma, Neurology, Cardiology, Thyroid, and Others)) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)
According to the report Asia Pacific Nuclear Imaging Industry, published by Market Data Forecast, The Industry was worth $3.13 billion in 2016 and estimated to be growing at a CAGR of 9.64%, to reach $4.96 billion by 2021.
Medical imaging is the method of generating a photographic image of the inside of the body for medical intervention. These devices aid in creating a databank of normal anatomy and physiology of internal organs so that any irregularity can be observed immediately.
Nuclear imaging is most commonly utilized for cardiovascular and oncology applications.
It refers to the method of generating visuals of the organs of the body by processing minor quantity of radioactive tracers. The images are obtained using a gamma camera and can be documented on film or on a computer.
Browse Market data tables and in-depth TOC of the Asia Pacific Nuclear Imaging Industry to 2021 at www.marketdataforecast.com/market-…ging-market-1626/
The growth of the Asia Pacific Nuclear Imaging Industry is mainly due to factors such as an increase in the number of cancer and cardiovascular disease cases, predilection towards minimally invasive procedures, ready availability of radiopharmaceuticals, and improving healthcare infrastructure in developing Industrys. However, factors such as costly procedures & equipment, inadequate number of trained medical staff, and shortage of supplies are hampering the growth of the Industry in this region.
The Asia Pacific Nuclear Imaging Industry is segmented based on Diagnostic Technologies and Application. The Industry for Nuclear Imaging, on the basis of Diagnostic Technologies is segmented into PET Radioisotopes and SPECT Radioisotopes.
PET Radioisotopes are further segmented into Rubidium-82, Fluorine-18, whereas SPECT Radioisotopes are further segmented into Thallium-201, Technetium-99m, Xenon-133, and Iodine-123. On the basis of Application, the Nuclear Imaging Industry is segmented into PET and SPECT.
PET is further segmented into Cardiology, Oncology, and Neurology, whereas SPECT is segmented into Lymphoma, Neurology, Cardiology, and Thyroid. PET is mainly being utilized in oncology due to superior quality of imaging; Whereas SPECT is used in the cardiology section accounting for almost 80% of the entire cardiology Industry share.
The Asia Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia. Among Asia Pacific countries, India, Japan, and Australia will be the substantial Industrys due to growing healthcare budgets and rising popularity of several radiopharmaceuticals in numerous clinical indications.
Companies are showing a strong interest in enhancing image quality by developing new technologies and creating new devices or novel techniques to achieve images with higher spatial resolution. The major companies dominating the Nuclear Imaging Industry in this region are Mallinckrodt plc, Siemens Medical Solutions, Hitachi Medical Corporation, Medtronic Inc., General Electric Co.
(healthcare division), IBA Group, Positron Corporation, Philips Medical Systems, Naviscan, Toshiba Medical Systems Corporation, Carestream Health, Lantheus Medical Imaging Inc., Cardinal Health Inc., and Bayer AG.
Key Points from Table of Contents
- Executive Summary
- Key Inferences
- New Developments
Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
Asia Pacific Nuclear Imaging Industry: Segmentation
- Diagnostic Technologies
o PET Radioisotopes
o SPECT Radioisotopes
- South Korea
- PESTLE analysis
- Porter’s Five analysis
Industry Leaders' Analysis
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information:Make an Inquiry about this report HERE!